Improving Sleep to Prevent Depression & Anxiety in Adolescents at High Risk
Launched by UNIVERSITY OF CALGARY · Apr 5, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how improving sleep can help prevent depression and anxiety in teenagers who are at higher risk. Researchers want to see if a short program called Cognitive Behavioral Therapy for Insomnia (CBT-I), which helps people with sleep problems, can also reduce feelings of sadness and anxiety in adolescents. The study will focus on teenagers aged 12 to 18 who have at least one parent with a history of depression or anxiety but do not have significant mental health issues themselves.
To participate, teens need to have some trouble sleeping, indicated by a score of 10 or higher on a sleep assessment tool. However, those with other serious sleep disorders or untreated mental health issues will not be eligible. If chosen to take part, participants can expect to engage in a brief therapy program designed to improve their sleep. This study aims to gather important information on how better sleep can support mental well-being in young people at risk for depression and anxiety.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Between the ages of 12 and 18.
- • Having at least one parent with a history of depressive or anxiety disorders but having no clinically significant history (per the Diagnostic and Statistical Manual of Mental Disorders 5) of internalizing disorders themselves.
- • Adolescents who score 10/25 or greater on the Insomnia Severity Index, indicating subthreshold insomnia or greater.
- Exclusion Criteria:
- • Experiencing symptoms of sleep disorders other than insomnia (i.e. restless legs syndrome \[RLS\], sleep-disordered breathing \[SDB\].
- • Having a history of untreated, serious psychiatric illness (i.e., bipolar disorder, schizophrenia).
- • Active suicidal ideation.
- • Currently taking prescribed medications for sleep problems.
- • Moderate to severe head injury.
About University Of Calgary
The University of Calgary is a leading research institution dedicated to advancing health and science through innovative clinical trials. With a strong emphasis on multidisciplinary collaboration, the university's clinical research initiatives aim to address pressing health challenges and improve patient outcomes. The institution fosters a robust environment for academic inquiry, leveraging state-of-the-art facilities and a diverse network of experts in various fields. Committed to ethical research practices and community engagement, the University of Calgary strives to translate scientific discoveries into tangible benefits for society.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Calgary, Alberta, Canada
Patients applied
Trial Officials
Daniel Kopala-Sibley, PhD
Principal Investigator
University of Calgary
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported